AZVUDINE
New Drug Approvals
JULY 18, 2025
Detailed numbers are provided by Genuine in the slides and the medication package insert. [14] 24] Roche held one 2002 patent, CNA028118480A (CN1516590A), over the broader class of 4′-substituted nucleotides. Common (> 1%) side effects include nausea, elevated blood lipids, fever, insomnia, tiredness, and diarrhea.
Let's personalize your content